🇺🇸 Losartan Tablets in United States
66 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 66
Most-reported reactions
- Drug Ineffective — 11 reports (16.67%)
- Product Substitution Issue — 9 reports (13.64%)
- Hypertension — 8 reports (12.12%)
- Dyspnoea — 7 reports (10.61%)
- Asthenia — 6 reports (9.09%)
- Abdominal Discomfort — 5 reports (7.58%)
- Acute Kidney Injury — 5 reports (7.58%)
- Cough — 5 reports (7.58%)
- Dizziness — 5 reports (7.58%)
- Headache — 5 reports (7.58%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Losartan Tablets approved in United States?
Losartan Tablets does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Losartan Tablets in United States?
Istituto Auxologico Italiano is the originator. The local marketing authorisation holder may differ — check the official source linked above.